Reply to “Reconsidering dopaminergic modulation in Alzheimer's disease: A case for levodopa/carbidopa as a disease‐modifying agent” is a research paper published in Alzheimer s & Dementia (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
European Union's Horizon 2020
Grant: 952334
Excellence Hub on Phase Transitions in Aging and Age-Related Disorders
National Funds through FCT-Fundação para a Ciência e a Tecnologia
Grant: PTDC/QUICOL/2444/2021
National Funds through FCT-Fundação para a Ciência e a Tecnologia
Grant: CEECIND/03750/2017/CP1386/CT0014
National Funds through FCT-Fundação para a Ciência e a Tecnologia
Grant: UIDB/04293/2020
Intramural NIH HHS
Grant: Z01 CT000014
Fields of Study
Keywords